NDC 81033-015-05 - NYSTATIN

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
81033-015
Requested NDC
81033-015-05
Package NDCs from labels
81033-015-16, 81033-015-60, 81033-015-05, 81033-015-01, 81033-015-54
Manufacturer
Kesin Pharma Corporation
Effective date
2026-06-30
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
NYSTATIN - Kesin Pharma CorporationKesin Pharma Corporation2026-06-30HUMAN PRESCRIPTION DRUG LABEL
NYSTATIN - Kesin Pharma CorporationKesin Pharma Corporation2025-12-11HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81033-015-01NYSTATIN100 in 1 CASESUSPENSION1002
81033-015-05NYSTATIN5 mL in 1 CUP, UNIT-DOSESUSPENSION52
81033-015-54NYSTATIN50 in 1 CARTONSUSPENSION502

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
81033-015-01ML - Milliliter81033-0152cfb8a81-2eb0-4024-8476-284f8d06333612026-03-17
81033-015-05ML - Milliliter81033-01549867bf3-a8d3-4975-bb87-7df54876759212026-03-17
81033-015-54ML - Milliliter81033-01524ab3546-05de-4da6-a3a5-dadae4b1265b12026-03-17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 34 · 666 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lights Lemon GlycerinGLYCERINLights Medical Manufacture Co., Ltd.c38638af-f367-4780-8295-022d959e79ca2026-11-09WarningsExact identifier
unii: PDC6A3C0OX
BEVERHILL HAIR TONICUNDARIA PINNATIFIDA EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, MORUS ALBA BARK EXTRACT, PINUS DENSIFLORA LEAF EXTRACT, ARTEMISIA VULGARIS EXTRACT, SESAMUM INDICUM SEED EXTRACT, SODIUM BENZOATEBIOHERB Co., Ltd.32733977-606e-f110-e063-6294a90aba8f2026-11-06WarningsExact identifier
unii: OJ245FE5EU
GlycerinGLYCERINBeijing Jingfeng Pharmaceutical (Shandong) Co., Ltd552e16b9-f46a-7838-e063-6394a90ab8aa2026-11-04WarningsExact identifier
unii: PDC6A3C0OX
Lemon Glycerine SwabsticksGLYCERINEPHOENIX HEALTHCARE SOLUTIONS, LLC436919f7-14cd-4318-9388-b3e1cbec176b2026-11-03WarningsExact identifier
unii: PDC6A3C0OX
hemorrhoidalGLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUMShield Line LLC5f635795-cb5b-cab4-e063-6394a90a7a9a2026-11-03WarningsExact identifier
unii: PDC6A3C0OX
Huddle Barrier BalmGLYCERINBetter Barrier Co.5b3cf1ed-082b-15cf-e063-6394a90a688e2026-11-02WarningsExact identifier
unii: PDC6A3C0OX
NystatinNYSTATINCardinal Health 107, LLC56aca0e2-8691-4701-beba-e2315524709f2026-10-27Adverse reactionsExact identifier
rxcui: 312055
unii: BDF1O1C72E
GlycerinGLYCERINChain Drug Marketing Association Inc.424d91f0-ecf9-6d9b-e063-6394a90a80062026-10-26WarningsExact identifier
unii: PDC6A3C0OX
URIMAR-T CAPSMETHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATEAllegis Pharmaceuticals, LLCcf7c3d65-11d2-49cd-b207-8ccc6a221fe02026-10-26Warnings, Adverse reactionsExact identifier
unii: 593YOG76RN
MB CAPSMETHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATEAllegis Pharmaceuticals, LLC2efeb281-b84b-4750-e063-6394a90a27ee2026-10-26Warnings, Adverse reactionsExact identifier
unii: 593YOG76RN
Family Wellness HEMORRHOIDGLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCLFAMILY DOLLAR (Family Wellness)16ceb129-5c0a-428a-a867-cfbbb08bb62a2026-10-26WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Incd81c1a4f-87b0-ee8c-e053-2995a90af9e52026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc9e96976b-2990-79e0-e053-2995a90a0f292026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc376e0289-28e9-e87f-e063-6294a90a3b042026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Incf452a2c4-c869-7bf5-e053-2995a90ac1a02026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc10c3e31d-779d-8ff6-e063-6294a90acd392026-10-25WarningsExact identifier
unii: PDC6A3C0OX
OptaseGLYCERINScope Health Inc86c14327-ffc7-806e-e053-2991aa0aaf922026-10-25WarningsExact identifier
unii: PDC6A3C0OX
Clear Eyes Maximum Redness ReliefNAPHAZOLINE HYDROCHLORIDE AND GLYCERINPrestige Brands Holdings, Inc.c3b0e344-68dd-4c35-bf46-744e612a5b152026-10-23WarningsExact identifier
unii: PDC6A3C0OX
NystatinNYSTATIN CREAMRedpharm Drug5e56fa99-3244-0b7b-e063-6394a90af4a12026-10-21Adverse reactionsExact identifier
unii: BDF1O1C72E
SODIUM PHOSPHATESSODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEAmneal Pharmaceuticals Private Limited62db5220-13ec-4cb9-b705-8a908a174dba2026-10-16Warnings, Adverse reactionsExact identifier
unii: 70WT22SF4B
unii: 593YOG76RN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.